CAS 883553-87-5

Pemetrexed L-Glutamyl-L-glutamic Acid

Description:

Pemetrexed L-Glutamyl-L-glutamic Acid, identified by its CAS number 883553-87-5, is a compound that combines the chemotherapeutic agent pemetrexed with amino acids, specifically L-glutamic acid and L-glutamyl acid. Pemetrexed itself is an antifolate drug primarily used in the treatment of certain types of cancer, including non-small cell lung cancer and mesothelioma. The addition of L-glutamic acid may enhance the drug's solubility and bioavailability, potentially improving its therapeutic efficacy. This compound exhibits characteristics typical of both small molecule drugs and amino acids, including the ability to interact with biological systems through various mechanisms, such as inhibiting enzymes involved in folate metabolism. Its structure likely includes multiple functional groups that contribute to its pharmacological properties. As with many chemotherapeutic agents, the safety profile, including potential side effects and interactions, is an important consideration in its clinical use. Further research is essential to fully understand its pharmacodynamics and pharmacokinetics in cancer therapy.

Formula: C₂₅H₂₈N₆O₉

Synonyms:

• Famitinib Impurity 1
• L-Glutamic acid, N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-α-glutamyl-
• Pemetrexed L-Glutamyl-L-glutamic Acid

Pemetrexed L-Glutamyl-L-glutamic Acid

Controlled Product

CAS: 883553-87-5

Formula: C₂₅H₂₈N₆O₉

Color and Shape: Neat

Molecular weight: 556.525

Ref: TR-P219565